Abstract:Introduction Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a urologic chronic pelvic pain syndrome with an unknown etiology and a variety of somatic and psychological symptoms, including elevated levels of anxiety and depression (Crawford, 2019). This often causes substantial impairment to quality of life: it is well known that unaddressed psychosocial elements of chronic pain can shape patient perceptions and behavior, and are associated with poorer functioning, adjustment, prognosis, and response to treatment (Piontek et al., 2022). Investigating the role of psychosocial factors in IC/BPS increase over the last years; however, prior to the last 5 years, there had been a scarcity of research on psychosocial factors compared to that in similar conditions (Windgassen et al., 2020). Objective Despite recommendations for the inclusion of non-pharmacological treatment in the management of IC/BPS, the focus so far has predominantly been on the inclusion of physical therapies with minimal discussion of psychological interventions. Therefore, this review aimed to examine the most recent studies regarding anxiety and depression in patients with IC/BPS, to stress the urgency of considering multidisciplinary care for individuals with this debilitating condition. Methods A literature search (PubMed and Google Scholar) of the past 5 years (January 2018 – March 2023) was conducted using key words related to IC/BPS, anxiety and depression, e.g., "(Interstitial cystitis OR Bladder pain syndrome) AND (Anxiety OR Depression OR Depressive disorder OR Psychology)". The inclusion criteria were: to be empirical studies, to have been published within the last 5 years, to have included in the protocol measurements of anxiety and/or depression. A total of 28 studies were selected. Results There is a high rate of psychosocial comorbidities in IC/BPS; in particular, elevated levels of anxiety and depression, which are highly correlated with each other and with pain intensity. In addition, pain catastrophizing and helplessness seem to have a key role in the maintenance of the negative relationship between depression and pain over time in IC/BPS. Thus, there appears to be a complex interaction between psychopathologic and somatic symptoms. We assume that changes in mood and anxiety share a bidirectional relationship with IC/BPS pain severity: if pain increases, mood and anxiety likely worsen and, similarly, if mood and anxiety worsen it predicts an increased level of pain will follow. Conclusions IC/BPS is a complex condition that requires a management plan beyond the biomedical approach. Indeed, the psychological impact of IC/BPS is pervasive and severe. Our review supports the findings of previous studies that showed patients with this condition have a significantly higher risk of experiencing mental-emotional disorders compared to those without. These findings further strengthen the evidence base showing that anxiety and depression may not only be a consequence of this chronic pain condition but may also be involved in its maintenance. Our results suggest that it is crucial addressing anxiety and depression as early as possible in biopsychosocially oriented therapeutic interventions for patients with IC/BPS. Therefore, it is recommended that health care providers conduct a thorough assessment of this condition to identify therapeutic goals to pursue and possibly consider a multidisciplinary approach. Disclosure No.

What is in the pipeline for new treatments for bladder pain syndrome/ interstitial cystitis?

Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome

Interstitial Cystitis/Bladder Pain Syndrome: a Review and an Update

Progress in the diagnosis and treatment of interstitial cystitis/bladder pain syndrome

The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome

Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis

Current updates relating to treatment for interstitial cystitis/bladder pain syndrome: systematic review and network meta-analysis

Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome

Intravesical Bladder Treatment and Deep Learning Applications to Improve Irritative Voiding Symptoms Caused by Interstitial Cystitis: A Literature Review

Immunotherapy options for painful bladder syndrome: what's the potential?

New therapeutic approach with extracellular vesicles from stem cells for interstitial cystitis/bladder pain syndrome

Quality of Life and Treatment Modalities in Patients with Interstitial Cystitis: The Patients' Perspective

The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans

Stem cell therapy for interstitial cystitis/bladder pain syndrome

Definition Change and Update of Clinical Guidelines for Interstitial Cystitis and Bladder Pain Syndrome

Cognition, Emotion, and the Bladder: Psychosocial Factors in Bladder Pain Syndrome and Interstitial Cystitis (BPS/IC)

Beyond the urothelium: Interplay between autonomic nervous system and bladder inflammation in urinary tract infection, bladder pain syndrome with interstitial cystitis and neurogenic lower urinary tract dysfunction in spinal cord injury-ICI-RS 2023

Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis

This pain drives me crazy: Psychiatric symptoms in women with interstitial cystitis/bladder pain syndrome

(213) Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review Regarding Anxiety and Depression

Cytokines in Bladder Pain Syndrome: A Review of the Literature